Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionNon-steroidal agonist of farnesoid X receptor (FXR; NR1H4)
Molecular Target Farnesoid X receptor (FXR) (NR1H4)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationNon-alcoholic steatohepatitis (NASH)
Indication DetailsTreat non-alcoholic steatohepatitis (NASH)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today